Evans, Marc

Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

Currie, C. J., Peters, J. R., Tynan, A., Evans, M., Heine, R. J., Bracco, O. L., Zagar, T., & Poole, C. D. (2010) · The Lancet

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 874

Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes

Currie, C. J., Poole, C. D., Evans, M., Peters, J. R., & Morgan, C. L. (2013) · The Journal of Clinical Endocrinology & Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 203

Drug therapy in obesity: a review of current and emerging treatments

Williams, D. M., Nawaz, A., & Evans, M. (2020) · Diabetes Therapy

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 195

Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review

Pearce, I., Simó, R., Lövestam‐Adrian, M., Wong, D. T., & Evans, M. (2019) · Diabetes, Obesity and Metabolism

Retinal Diseases and TreatmentsDiabetes Management and Research

Cited by 180

Endothelial dysfunction in hypopituitary adults with growth hormone deficiency

Evans, M., Davies, Goodfellow, Rees, & Scanlon (1999) · Clinical Endocrinology

Growth Hormone and Insulin-like Growth FactorsCardiovascular Health and Disease Prevention

Cited by 129

Real-world associations of renin-angiotensin-aldosterone system inhibitor dose, hyperkalemia, and adverse clinical outcomes in a cohort of patients with new-onset chronic kidney disease or heart failure in the United Kingdom

Linde, C., Bakhai, A., Furuland, H., Evans, M., McEwan, P., Ayoubkhani, D., & Qin, L. (2019) · Journal of the American Heart Association

Potassium and Related DisordersRenin-Angiotensin System Studies

Cited by 110

Fast-acting insulin aspart: the rationale for a new mealtime insulin

Evans, M., Wilkinson, M., & Giannpolou, A. (2019) · Diabetes Therapy

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 23

Increased risk of severe hypoglycemic events with increasing frequency of non-severe hypoglycemic events in patients with type 1 and type 2 diabetes

Sreenan, S., Andersen, M., Thorsted, B. L., Wolden, M. L., & Evans, M. (2014) · Diabetes Therapy

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 21

Evaluation of the effectiveness of liraglutide and sitagliptin in type 2 diabetes: a retrospective study in UK primary care

Nyeland, M. E., Ploug, U. J., Richards, A., Garcia Alvarez, L., Demuth, D., Muthutantri, A., Skovgaard, R., & Evans, M. (2015) · International Journal of Clinical Practice

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 21

Risk of Stroke in Real-World US Individuals with Type 2 Diabetes Receiving Semaglutide or a Dipeptidyl Peptidase 4 Inhibitor

Evans, M., Husain, M., Srivastava, A., Mangla, K. K., Kuhlman, A. B., & Lingvay, I. (2024) · Advances in Therapy

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 13

Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical Practice

Evans, M., Morgan, A. R., Bain, S. C., Davies, S., Hicks, D., Brown, P., Yousef, Z., Dashora, U., Viljoen, A., Beba, H., et al. (2022) · Diabetes Therapy

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 10

Practical Approaches to Continuous Glucose Monitoring in Primary Care: A UK-Based Consensus Opinion

Fernando, K., Alabraba, V., Welsh, J. B., Seidu, S., Strain, W. D., Bell, H. E., Davies, S., & Evans, M. (2025) · Diabetes Therapy

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 7